COPD药物-话题@MedSci - 梅斯（MedSci）

#COPD药物#

8篇内容 | 1165人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1545505, encodeId=9cc41545505ba, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=维罗纳制药的COPD药物恩替芬碱获得另一项欧盟专利, objectType=article, longId=163981, objectId=59751639814b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59751639814b, replyNumber=0, likeNumber=72, createdTime=2019-04-11, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59751639814b, moduleTitle=维罗纳制药的COPD药物恩替芬碱获得另一项欧盟专利, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=59751639814b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545504, encodeId=02091545504b1, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=GSK的COPD药物Relvar Ellipta积极临床试验结果, objectType=article, longId=69500, objectId=78d96950032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78d96950032, replyNumber=0, likeNumber=83, createdTime=2016-06-01, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78d96950032, moduleTitle=GSK的COPD药物Relvar Ellipta积极临床试验结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=78d96950032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545503, encodeId=df4015455031e, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=Am J Respir Crit Care Med：COPD药物治疗对心肺血管和功能都有有利影响, objectType=article, longId=58822, objectId=491958822ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=491958822ed, replyNumber=0, likeNumber=62, createdTime=2015-11-16, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=491958822ed, moduleTitle=Am J Respir Crit Care Med：COPD药物治疗对心肺血管和功能都有有利影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=491958822ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545502, encodeId=a2711545502c4, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=GSK与Theravance携手开发新COPD药物, objectType=article, longId=38061, objectId=9318380617a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9318380617a, replyNumber=0, likeNumber=65, createdTime=2014-07-23, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9318380617a, moduleTitle=GSK与Theravance携手开发新COPD药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9318380617a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545501, encodeId=2a1515455011d, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=诺华COPD药物Onbrez疗效与GSK Seretide媲美, objectType=article, longId=34602, objectId=28f8346027d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28f8346027d, replyNumber=0, likeNumber=84, createdTime=2014-05-14, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28f8346027d, moduleTitle=诺华COPD药物Onbrez疗效与GSK Seretide媲美, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=28f8346027d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545500, encodeId=1508154550049, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=森林实验室（Forest Lab） COPD药物Aclidinium获FDA批准, objectType=article, longId=8430, objectId=45758430f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45758430f1, replyNumber=0, likeNumber=0, createdTime=2012-08-03, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45758430f1, moduleTitle=森林实验室（Forest Lab） COPD药物Aclidinium获FDA批准, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45758430f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545499, encodeId=4d4c1545499cb, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=勃林格殷格翰COPD药物olodaterol II期研究取得积极结果, objectType=article, longId=6482, objectId=d815648236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d815648236, replyNumber=0, likeNumber=66, createdTime=2012-05-26, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d815648236, moduleTitle=勃林格殷格翰COPD药物olodaterol II期研究取得积极结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d815648236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1545498, encodeId=e6241545498de, content=<a href='/topic/show?id=3bc05091eb' target=_blank style='color:#2F92EE;'>#COPD药物#</a>, objectTitle=诺华COPD药物QVA149 首批3项III期研究达主要目标, objectType=article, longId=5412, objectId=12db541285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12db541285, replyNumber=0, likeNumber=63, createdTime=2012-04-18, rootId=0, userName=jingyanzhu715_39486105, userId=28d413759111, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12db541285, moduleTitle=诺华COPD药物QVA149 首批3项III期研究达主要目标, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12db541285)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

COPD药物

2020-05-29

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

维罗纳制药的COPD药物恩替芬碱获得另一项欧盟专利

2019-04-11

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

GSK的COPD药物Relvar Ellipta积极临床试验结果

2016-06-01

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

Am J Respir Crit Care Med：COPD药物治疗对心肺血管和功能都有有利影响

2015-11-16

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

GSK与Theravance携手开发新COPD药物

2014-07-23

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

诺华COPD药物Onbrez疗效与GSK Seretide媲美

2014-05-14

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

森林实验室（Forest Lab） COPD药物Aclidinium获FDA批准

2012-08-03

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

勃林格殷格翰COPD药物olodaterol II期研究取得积极结果

2012-05-26

jingyanzhu715_39486105 (审核中...)

前往app查看评论内容

#COPD药物#

诺华COPD药物QVA149 首批3项III期研究达主要目标

2012-04-18

科室
- - 订阅+
  - 更多科室
工具
服务